Bottom line Retatrutide is still in clinical trials, with early data suggesting significant weight loss potential, while semaglutide has FDA approval with proven efficacy and safety history
However, room temperature storage must not exceed the specified temperature limits, and medications should never be exposed to direct sunlight or heat sources such as windowsills, car interiors, or near appliances
Seek medical attention if you develop upper right abdominal pain, fever, or yellowing of the skin or eyes (jaundice)
Injecting into muscle can lead to faster absorption, more bleeding, and side effects like nausea
On one side, there are brand-name medications like Wegovy, Ozempic, Mounjaro, and Zepbound manufactured by Novo Nordisk and Eli Lilly, FDA-approved, and widely advertised
One example escalation schedule observed in Phase 2 obesity trials proceeded broadly as follows: Weeks 14: 2 mg once weekly (initiation phase) Weeks 58: 4 mg once weekly Weeks 912: 8 mg once weekly Weeks 13 onwards: Up to 12 mg once weekly (the maximum dose explored in Phase 2 trials) This is an illustrative example only